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Introduction
 According to the International Agency for Research 
on Cancer (IARC), 12.7 million people were diagnosed 
with cancer and 7.6 million died from cancer worldwide 
in 2008 (Ferlay et al., 2010). Cancer registries are 
fundamental components of the infrastructure for cancer 
control programs and data collection and analysis. 
 A Cancer Registration system includes systematic 
collection, storage, analysis, interpretation and reporting of 
cancer-related data. The two main types of cancer registry 
are the hospital-based and population-based cancer 
registries (PBCRs). Hospital-based cancer registries are 
concerned with recording cancer patient’s information in 
a particular hospital, while PBCRs collect data on all new 
FDVHVRIFDQFHULGHQWLÀHGLQDZHOOGHÀQHGSRSXODWLRQ,Q
many countries, especially high-income countries, PBCRs 
have been established for a long time and play a critical 
role in the determination of cancer incidence and mortality. 
PBCRs thus allow for the measurement of a population’s 
cancer burden and provide critical information for the 
planning and monitoring of cancer control programs 
(Silva, 1999). Although more than half of new cancer cases 
occur in low- or middle-income countries, many such 
countries lack a well-functioning cancer registry (Parkin, 
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Abstract
 In December 2011, the Cancer Research Centre of the Cancer Institute of Iran sponsored a 3-day workshop 
on “Cancer Registration Principle and Challenges in Iran”, which convened cancer registry experts. The 
objectives of the workshop were: to introduce standard cancer registration, to review the policy and procedure 
of cancer registration in Iran, and to review the best practices in the cancer registries in Iran. Challenges to 
cancer registration were discussed and recommendations were developed. The workshop was evaluated by 
participants for better organization of subsequent workshops. The objective of publication of this report is that 
based on Cancer in 5 Continents, many low- or middle-income countries do not meet the criteria for a standard 
population-based cancer registry (PBCR); on the other hand cancer is the most important cause of mortality 
and the essential part of any cancer control program is the cancer registry. Therefore this report focuses on 
problems and challenges of PBCR and provides recommendations which might help other developing countries 
to decrease their PBCR defects. 
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2006), and this needs to be prioritized. Zendehdel et.al 
showed trends in the number of PBCR in the world from 
1960-2002 (Keshtmand, 2011) (Table1). According to this 
table PBCR in Europe and USA increasingly established 
in four decades but in Africa and Asia this growth trend 
was not visible. Although in high-income countries the 
coverage of PBCR is almost 100% but in low- or middle-
income countries this coverage hardly is 30%, on the other 
hand PBCR coverage in Africa is 1.4%, in western Asia 
8.7%, in South-central Asia 23.4%, in Eastern Asia 4.1%, 
in South-eastern Asia 2% and in South-central America 
4.4% (Keshtmand, 2011). Several obstacles have been 
proposed to impede the development of cancer registries 
in low- or middle-income countries including: a shortage 
of basic health services and trained personnel, a lack of 
follow-up, limited census data, a lack of data-processing 
facilities, lack of population stability, poor individual 
LGHQWLÀFDWLRQDQGDODFNRIFRQÀGHQWLDOLW\6LOYD
 The first cancer registry in Iran began reporting 
in 1960. In 1969, reports showed a high incidence of 
esophageal cancer in northern Iran. After this report, 
WKHÀUVWFDQFHUUHJLVWU\ZDVHVWDEOLVKHGLQ0D]DQGDUDQ
province in northern Iran. The Caspian littoral area that 
Mazandaran is a part of, has a high incidence of esophageal 
cancer and is part of the infamous Asian esophageal 
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cancer belt (Mohagheghi and Mosavi-Jarrahi, 2010). 
The Mazandaran registry was a result of collaboration 
with the IARC. The most sophisticated PBCR in Iran 
was established by the Cancer Institute of Iran in 1993 to 
register new cancer cases in the Teheran metropolitan area 
(Mohagheghi and Mosavi-Jarrahi, 2010). Other PBCRs 
were established in Ardabil and Golestan Provinces 
(Mohagheghi and Mosavi-Jarrahi, 2010). At present, most 
provinces have implemented a pathology-based registry 
system under the supervision of the Ministry of Health, 
and some provinces have recently established PBCRs 
(Mohagheghi and Mosavi-Jarrahi, 2010). However, 
none of the PBCRs meet standard criteria, and their 
data have not been included in the Cancer Incidence in 
Five Continents database (Zendehdel et al., 2011). As a 
result, the Cancer Research Centre of Cancer Institute of 
Iran ran a workshop where it reviewed different aspects 
of standard cancer registration. In addition, during the 
workshop, different activities of cancer registration in Iran 
were evaluated and recommendations for improvement 
were discussed. In this paper, we report the details of this 
workshop and discuss the recommendations that were 
made. We also thought this workshop can help other 
developing countries especially West Asian countries due 
to similar problems in establishing standard PBCR. 
Objectives of the Workshop
 The purpose of the workshop was to bring together 
various stakeholders and interested researchers to: 
i) Introduce standard cancer registry system based 
on international standards; ii) Review the policy and 
procedure of cancer registry in Iran; iii) Identify the 
strengths and weaknesses of cancer registry in Iran; 
iv) Review the best practices in the cancer registration 
activities in Iran; and v) Discuss strategies for improving 
PBCR in the country.
 The workshop was held from 20-22, December 2011 
at Cancer Research Centre of Cancer Institute. The 
content of the workshop was designed based on IARC 
summer school on cancer registration, Cancer Registration 
Principals and Methods book (Jensen et al., 1991) and 
presentation of the cancer registration activities in the 
country. The workshop was followed by an expert panel in 
which the panelists discussed the challenges and suggested 
improvement strategies for cancer registration in Iran. 
Participants
 7KLUW\ÀYHSDUWLFLSDQWVLQFOXGLQJSDWKRORJLVWVQ 
PHGLFDOUHFRUGH[SHUWVQ PHGLFDORQFRORJLVWVQ 
JHQHUDOSUDFWLWLRQHUV Q  HSLGHPLRORJLVWV DQGSXEOLF
KHDOWKSURIHVVLRQDOVQ SDUWLFLSDWHGLQWKHZRUNVKRS
Day One
Introduction and importance of cancer registration 
 ,QWKHÀUVWVHVVLRQFDQFHUUHJLVWUDWLRQDQGLWVUROHLQ
the cancer control program was discussed. In addition, 
role of international organizations on the promotion of 
cancer registries and their standards were explained. In 
overall, 12.7 million new cancer cases and 7.6 million 
cancer deaths were reported in 2008 worldwide. From 
these cases, 56% of the cancers and 63% of the deaths 
occurred in low- and middle-income countries. The most 
commonly diagnosed cancers in the world were lung, 
breast, and colorectal cancers; and the most prevalent 
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Table 1. Trends in the Number of Population Based Cancer Registries Published in the IARC Monograph 
Cancer in Five Continents (CI5) From 1960 to 2002 [with the Permission of Basic and Clinical Cancer Research 
Journal (BCCR)]
Region Frequency of cancer registry reports published in different volume of CI5 (Volume)
 Volume I Volume II Volume III Volume IV Volume V Volume VI Volume VII Volume VIII Volume IX
 1960-1962 1963-1967 1968-1972 1973-1977 1978-1982 1983-1987 1988-1992 1993-1997 1998-2002
Africa 4 5 3 1 0 3 5 5 5
South-Eastern Asia  1 0 3 3 3 5 6 10 8
South central Asia 0 1 1 2 5 5 6 10 8
Western Asia 1 1 1 1 3 3 3 4 8
Eastern Asia  1 2 3 6 7 10 11 20 21
Eastern Europe 0 8 9 10 7 13 7 8 8
Northern Europe  9 10 13 15 20 23 20 21 20
Western Europe 2 2 4 8 13 17 22 27 33
Southern Europe  1 1 3 4 6 17 26 32 39
Austrailia and Newzeland 1 1 1 3 8 7 7 9 9
South-central America 3 2 5 4 6 8 10 9 10
North Aemrica and Canada 7 10 16 21 25 26 27 27 55
World 30 43 62 78 103 137 150 182 224
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Table 2. ASR of Most Common Cancer in Iranian 
Female in 2008
Cancer type Golobocan 2008 National Cancer Registry Iran
 ASR Frequency No. ASR* Frequency No.
  (%)   (%)
Breast 18.4 26 5692 33.21 24.86 8424
Colorectal 6.4 7 1822 11.12 7.85 2658
Stomach 9 9.5 2453 10 6.95 2353
Esophagus 6.3 6.4 1661 7.77 5.26 1782
Thyroid 2.3 3 779 4.47 3.88 1314
Leukemia 4 5 1293 6.29 5 1693
Ovary 3.1 3.8 972 4.25 3.23 1096
Brain 2.1 2.6 685 3.09 2.64 894
Uterus 1.7 1.8 466 3.9 2.68 907
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cancer deaths were lung, stomach, and liver cancers. It 
was predicted that cancer incidence in the world would 
be 21.4 million in 2030, indicating that the number of 
new cases would increase up to 69%. During this period, 
the increase in cancer incidence will be 35% in the high-
income and 80% in low- and middle-income countries. 
 In addition to the role of cancer registry system in 
the monitoring and evaluation of cancer registration 
program and its action plans, it provides data for different 
epidemiological studies including descriptive, analytical, 
clinical, occupational, survival analysis and interventional 
projects.
 7KHÀUVW3%&5ZDVLPSOHPHQWHGLQLQ*HUPDQ\
This type of cancer registration is a process of systematic 
and continues data collection of reportable cases. PBCR 
LQFOXGHVHYHU\QHZFDVHVRIFDQFHULQGHÀQHGSRSXODWLRQ
in a given time. The general goal in PBCR is the process of 
evaluation and control of cancer effect on population and 
it is an essential part of any cancer control program. Data 
from cancer registry had been used in widespread areas of 
cancer control such as primary and secondary prevention, 
etiological research, evaluation of patient care, and health 
care planning. Overall, the goal of cancer registration is 
collecting and classifying, creating a linkage between 
information resources, evaluation of quality of data, and 
data analysis.
Introduction of international organizations and databases
 We devoted a session of the workshop to introduce 
international organizations and databases including: 
IARC, IACR, Globocan, SEER program, NAACCR, and 
European cancer registration network. 
 The International Association of Cancer Registries 
(IACR), a subset of World Health Organization (WHO), 
attempt to support cancer registries worldwide and 
suggests standard approaches to estimate incidence 
and mortality of cancer. IARC publishes the book titled 
Cancer in Five Continents. The book could be assumed as 
a peer review journal that publishes the data and reports 
of the standard cancer registries submitted to the IARC 
every four year. The procedure to accept or reject the 
applications could be assumed as an external evaluation. 
We should appreciate it and make the publication of results 
of our registries in this book as the main target and success 
indicator (Cancer). 
 IACR is a non-governmental organization and a 
professional association founded in 1966 to promote 
PBCR and related activities worldwide. The IACR 
facilitates the networking and trade of information 
between cancer registries all over the world to improve 
data quality (IACR). Globocan is a project in IARC 
which provides contemporary estimates of the incidence, 
mortality and prevalence from major type of cancers, at 
national level, for 184 countries of the world (Ferlay et 
al., 2010).
 Surveillance, Epidemiology and End Results (SEER) 
program is cancer statistics data base in the United States. 
This program produces information about incidence, 
prevalence and survival of cancer in 28% of US population 
and cancer mortality of all countries (Institute).
 The North American Association of Central Cancer 
Registries (NAACCR) is a cancer registry organization 
responsible for producing standard data, holding training 
course, evaluating PBCR and reporting cancer statistics 
(Registries).
 The European Network of Cancer Registries (ENCR) 
is another cancer registry organization which acts as a 
network between cancer registries in European countries 
(Registries). This organization produces standard data, 
trains cancer registry personnel, and publishes cancer 
statistics in Europe. 
 In Iran, all country covered by pathology-based cancer 
registry which is under supervision of Ministry of Health 
and most PBCRs were performed by research centers. 
Relying to evidences, pathology-based cancer registry data 
gathered by Ministry of Health is underestimated and it 
could not be replaced with PBCR (Zendehdel et al., 2011). 
Data from Ministry of Health in compare with Globocan 
2008 showed inconsistency in Age Standardized Incidence 
Rate (ASR) of some cancers (Cancer, Center for Disease 
Control and Prevention, 2008-2009) (Table2). However, 
recently the Ministry of Health launched PBCR registries 
and we should wait to see the high quality cancer registry 
from this initiative. We suggest application of standard 
approaches for the design and implementation of PBCR. 
Cooperation between research centers and Ministry of 
Health may strengthen this program. We should pilot 
all standards of the PBCR in a few provinces and apply 
the lessons learned from these provinces to extend the 
program to other regions. 
 Other challenges were lack of trained cancer registry 
personnel, poor supervision, and weak cooperation 
between cancer registries mitigate the success of cancer 
registration program in Iran. Establishment of cancer 
UHJLVWU\WUDLQLQJSURJUDPWUDLQLQJRIFHUWLÀHGUHJLVWUDUV
and providing continuous education for the pathologists 
may enhance the implementation of PBCR in the country. 
Day Two
Information technology and cancer registration 
 Nowadays information technology (IT) has become 
one of the important and necessary infrastructures in 
health. IT is the use of modern technology to aid the 
capture, storage, retrieval, analysis, and communication of 
information and it plays a crucial role in cancer registration. 
IT applications in cancer registration includes, but is not 
limited to: automated case alerts, data collection, better 
abstraction, quality checking-software, validation system, 
record linkage, analysis, e-Reporting, Management 
Information System (MIS), clinical trials information 
system, networking and collaboration. Challenges in 
cancer registration and information technology are privacy 
and confidentiality, data security, inadequate human 
resources, untrained personnel, no unique ID, minimal use 
RILQIRUPDWLRQWHFKQRORJ\GLIÀFXOW\LQXVHUWUDLQLQJORZ
quality in medical records, and change in culture. Lack 
of enough experience and capacity to apply automated 
approaches in cancer registry is another challenge at 
the moment in Iran and most low- and middle-income 
countries. The most important challenge is that how 
policy makers and stakeholders can use the information 
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for decision making. We believe that application of IT in 
the cancer registry system would improve the quality of 
cancer registry.
Discussion panel for cancer registration in Iran
 In the afternoon of the second day, the workshop 
was continued with a discussion about challenges and 
opportunities for the cancer registration in Iran. The session 
commenced with presentation of experiences from three 
PBCRs including Tehran, Golestan, and Ardabil PBCRs. 
Panelists were policy makers and experts who were in 
FKDUJHRIFDQFHUUHJLVWULHVDQGKDGVXIÀFLHQWNQRZOHGJH
in the design of surveillance systems and epidemiological 
research in cancer. All the panel members acknowledged 
the previous efforts made for the establishment of cancer 
registries in Iran. However, the standards of cancer 
registry, validity, and completeness, and timeliness of the 
PBCRs are not convincing yet. The main conclusions of 
this session include: i) Ongoing national pathology-based 
cancer registry is appreciated, but PBCRs should be 
started in different provinces; ii) Cooperation of cancer 
RIÀFHDQGUHVHDUFKFHQWHUVVKRXOGEHHQKDQFHGZLWKDQ
emphasis on the stewardship of ministry of health and 
medical education; iii) Feasibility and simplicity is a key 
indicator for a successful and sustainable cancer registry. 
We need to establish PBCRs in provinces that have more 
readiness and capacity for the design and management of 
the system; iv) We need to target international standards 
in the design and management of cancer registry; and v) 
Cancer registry data should be used for the evaluation of 
cancer control program and epidemiological research. 
Day Three
/HJDODVSHFWVDQGFRQÀGHQWLDOLW\LQFDQFHUUHJLVWU\
 One of the most important topics in cancer registration 
is legal aspects and confidentiality issues. Several 
countries have already introduced legislation on data 
confidentiality and data protection (Coleman et al., 
1992). Reporting of cancer cases to the registries can be 
compulsory or voluntary (Jensen et al., 1991). There is a 
JURZLQJSXEOLFDZDUHQHVVRIWKHFRQÀGHQWLDOLW\LVVXHDQG
concern over individual privacy. 
 Although the director of cancer registry is responsible 
IRU SUHVHUYLQJ WKH FRQÀGHQWLDOLW\ RI GDWD DOO WKH VWDII
of the registry at the time of employment should sign a 
VSHFLDOFRQWUDFWIRUWKHFRQÀGHQWLDOLW\DQGFRPSO\ZLWKLWV
regulation during their practice (Jensen et al., 1991). The 
security of electronic data is important and the registries 
must archive the electronic data in a secure and safe server. 
/HYHORIDFFHVVWRWKHGDWDVKRXOGEHGHÀQHGDFFRUGLQJWR
the purpose of the access. At the time of reporting cancer 
UHJLVWU\GDWD WKHSULQFLSOHRI FRQÀGHQWLDOLW\ VKRXOGEH
observed. We emphasized that all the users of registry 
GDWDVKRXOGEHDZDUHRIFRQÀGHQWLDOLW\LVVXHVDQGPXVW
comply with the regulation when using the data for the 
management and research purposes. 
 7KHUHDUHQRUHJXODWLRQYLVjYLVFRQÀGHQWLDOLW\LVVXHV
in Iranian cancer registries. However, the different levels 
RIFRQÀGHQWLDOLW\EDVHGRQLQWHUQDWLRQDOUHFRPPHQGDWLRQV
have been used. For example based on National Cancer 
Registry Guideline, in order to access to data from Cancer 
Registry, all researchers should have an approval from 
Ethical Committee. We suggest developing a national 
VWDQGDUGJXLGHOLQHIRUFRQÀGHQWLDOLW\LVVXHVLQWKHFDQFHU
registries and emphasize it in the different phase of the 
registry including data collection, management, data 
transfer, quality control, analyses, and data sharing. 
Cancer registry report
 The most important objective of cancer registry is 
UHSRUWLQJFDQFHUVWDWLVWLFV LQDZHOOGHÀQHGSRSXODWLRQ
The report is part of the health information system in 
countries and must include three main issues: background 
information, presentation and evaluation of the results, 
and tabular section.
 Background information must include description of 
registry, procedures and population coverage.
 Evaluations of result include consistency of number 
of cases in a particular year, site distribution, validity 
of diagnosis, demographic data, comparing report with 
VLPLODUDUHDWRÀQGGLIIHUHQFHV
 Tabular section must contain frequency distribution 
related to site of cancer, age, and sex. Noted graphical 
presentation is more attractive than tables. They present 
trends and comparability of cancer.
Workshop evaluation 
 We evaluated the workshop based on a questionnaire. 
In overall, 70% of the participants answered this 
TXHVWLRQQDLUHZHUHVDWLVÀHGZLWKWKHZRUNVKRSDQG
emphasized that workshops like this are needed to increase 
the knowledge of registration staff and improve the quality 
of cancer registry in the country. More than 70% suggested 
more practical sessions during the workshop. About 70% 
requested more advance workshops for the follow-up. 
 
Conclusion
We found this workshop a useful venue to discuss the 
challenges and shortcomings of the current registration 
practice. Network of cancer registries and its personnel 
may, by themselves, increase their awareness about the 
standards of cancer registries and, thereby, improve 
the quality of cancer registries in Iran. Due to a large 
demand for the training of different aspects of registry 
and variation of the audiences, different workshops for 
the training of the registrars and researchers are needed. 
Periodic workshops on data abstraction, ICD coding, 
information technology, data analyses, ethics, and 
FRQÀGHQWLDOLW\ LQFDQFHUUHJLVWU\DUHQHHGHG3URYLGLQJ
D QDWLRQDO FHUWLÀFDWLRQ IRU WKH UHJLVWUDUV DQG DVVLJQLQJ
WKHFHUWLÀHGUHJLVWUDUVLQWKHFDQFHUUHJLVWU\RIÀFHVODUJH
hospitals and pathology centers may also strengthen the 
registration practices in Iran. 
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